One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood.v126.23.377.377
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 10 |
Affiliation: Vanderbilt University, Virginia Commonwealth University Medical Center, University of California, Los Angeles, Duke Medical Center, Pharmacyclics (United States), AbbVie (United States), Medical University of South Carolina, City Of Hope National Medical Center, Cleveland Clinic, The University of Texas Southwestern Medical Center, Colorado Blood Cancer Institute, Carolinas Healthcare System, Levine Cancer Institute, Icahn School of Medicine at Mount SinaiCombination Treatment of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib and Carfilzomib in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Initial Results from a Multicenter Phase 1/2b Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
